The abrogation of PICALM significantly enhanced NIS expression and function in a similar manner to AP2α ablation, as well as blunting the induction of RAI uptake by CQ in thyroid cancer cells (Fig. 4I and 4J). This evidence concerns the gene SLC5A5 and thyroid cancer.